Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1012345...10...Last »

New $17 million Link Park will combine culture and productivity

Unique business park will be packed with amenities that focuses on investment in tenant, customer and employee happiness   August 4, 2015 (Kirkwood, N.Y.) – A new type of business park focused on employee satisfaction is making its way to the Southern Tier and will serve as the gateway to greater Binghamton business. Through the […]

Read More »

Heart effects of saturated fats may depend on overall diet

(Reuters Health) – While experts continue to debate the health effects of saturated fat, a new U.S. study suggests its link to heart disease depends on what else a person eats. Over time, cutting back on saturated fat was tied to a drop of up to 25 percent in heart disease risk – unless people […]

Read More »

Smart capsule to target colon diseases

A new electronic drug capsule engineered to deliver medications directly to the colon could potentially offer a more effective and cheaper option for treating people with gastrointestinal conditions, according to researchers at Purdue University in Indiana.   The device is comprised of two parts, one carrying a drug payload and the other housing electronics designed […]

Read More »

Walking while working may ease muscle pain

For many office workers, their job has literally become a pain in the neck. While standing desks are becomingly an increasingly popular option for those who suffer physical discomfort at work, a researcher at McGill University in Quebec says her study of treadmill workstations show them to be potentially more beneficial and able to help […]

Read More »

Israel’s MediWound signs $112 million deal in U.S. for burn treatment

Israel-based MediWound has signed a five-year, $112 million contract with the U.S. authority that handles public health medical emergencies to further develop and buy the company’s drug treatment for severe burns. Investment group Clal Biotechnology, which has a 45 percent stake in MediWound, said in a statement that the deal with the Biomedical Advanced Research […]

Read More »

WHO ramps up HIV drug push with call for early treatment for all

Everyone with HIV should be given anti-retroviral drugs as soon as possible after diagnosis, meaning 37 million people worldwide should be on treatment, the World Health Organization (WHO) said on Wednesday.   Recent clinical trials have confirmed that early drug use extends the lives of those with the AIDS-causing virus and cuts the risk of […]

Read More »

Webinar on Improving Clinical Trial Performance – October 2015

Media Alert: Webinar on Improving Clinical Trial Performance – October 2015   WHAT: CRO Analytics will host an upcoming webinar in October, “QPIs: What They Are And How They Drive Your KPIs”. This webinar will review the key concepts surrounding clinical trial metrics malpractice, performance measurement, and Quality Performance Indicators (QPIs); all topics put forth […]

Read More »

Astellas and Chromocell Announce License and Collaboration Agreement to Develop and Commercialize New Therapies to Treat Neuropathic Pain

Astellas obtains worldwide commercial rights to Chromocell’s novel, peripherally restricted NaV1.7 antagonist, CC8464 Chromocell receives $15 million in upfront payments and is eligible to receive over $500 million in development and commercial milestones plus double digit royalties on sales; additional development initiated by Chromocell could result in additional payments and co-promotion rights in the U.S. […]

Read More »

U.S. biotech to apply artificial intelligence to UK genome study

Berg, a private company that uses artificial intelligence to discover new drugs and diagnostics, will help England’s national genomics project mine DNA and health data from thousands of British citizens for potential drug targets. Berg, based in Boston, was co-founded in 2006 by Silicon Valley real estate billionaire Carl Berg. Since then, it has been […]

Read More »

Drug industry must address image problem over prices: Teva executive

Teva Pharmaceutical Industries Ltd’s research chief said on Tuesday the drug industry must act responsibly when it comes to pricing medications, given the mounting anger over the high cost of therapies in the United States.   Democratic presidential candidate Hillary Clinton brought new attention to the issue last week, proposing to cap patients’ treatment costs, […]

Read More »

Food tracking app links less sleeping to more eating

(Reuters Health) – Even people who think they eat three meals a day may actually graze for most of their waking hours and consume fewer calories when they get more sleep, a small U.S. study suggests. Researchers asked volunteers to use a mobile app to snap pictures of everything they ate and drank over three […]

Read More »

Clinton calls for repeal of Cadillac tax on high-end healthcare plans

U.S. Democratic presidential candidate Hillary Clinton called on Tuesday for the repeal of the “Cadillac tax” on premium health insurance plans that was created under President Barack Obama’s sweeping healthcare law. The move by Clinton, the Democratic front-runner in the 2016 White House race, is a break with the Obama administration that could win her […]

Read More »

More evidence links inactivity to diabetes and heart disease

(Reuters Health) – People who are inactive for hours on end each day may face an increased risk of diabetes and heart disease even if they also get regular exercise, a U.S. study confirms. While the study wasn’t designed to prove that a sedentary lifestyle causes heart disease or diabetes, the link between inactivity and […]

Read More »

Novavax RSV vaccine given to mothers safe for fetus: study

Novavax Inc said data from a mid-stage study showed that immunizing pregnant women with its RSV vaccine was safe for fetuses and could protect infants against the common respiratory virus. The Maryland-based biotechnology company, whose stock jumped about 8.5 percent in premarket trading on Tuesday, reported last month that a separate mid-stage study showed the […]

Read More »

Esperion Stock Plummets as Updates on ETC-1002 Proves Not Enough for Investors

ANN ARBOR, Mich. — Esperion Therapeutics, Inc. (ESPR)’s stock plummeted nearly 35 percent this morning after the company announced it will separately assess patients with statin intolerance following Phase II results. Esperion said it plans to conduct multiple Phase III clinical trials to “separately evaluate patients with statin intolerance, as well as patients who are […]

Read More »

Lilly, Incyte arthritis drug found better than common treatment

Eli Lilly and Co and Incyte Corp said their experimental drug was found to be more effective in treating rheumatoid arthritis than a commonly prescribed medicine, in a late-stage study. The drug, baricitinib, reduced signs and symptoms of the inflammatory disorder better than the decades-old treatment, methotrexate, after 24 weeks, the companies said on Tuesday. […]

Read More »

Zosano Terminates Eli Lilly Deal, Halts Daily Osteoporosis Drug Program

Fremont, Calif.-based Zosano Pharma, Inc. announced yesterday that it will halt development of its Daily ZP-PTH treatment intended for severe osteoporosis. It plans to resume development of its Weekly ZP-PTH product. Japan’s regulatory authorities required additional studies, which would have delayed the marketing of the product by at least a year in Japan. This prompted […]

Read More »

Sanofi says application for new diabetes drug under FDA review

European pharmaceuticals group Sanofi on Tuesday said its application for review for its new drug, lixisenatide, a diabetes treatment, had been accepted by the U.S. Food and Drug Administration.   (Reporting by Astrid Wendlandt) Source: Reuters Health

Read More »

Democrats take aim at drug prices, prompting sharp drops in biotech stocks

Democratic lawmakers on Monday attacked “massive” price increases of two heart drugs by Canada’s Valeant, fueling a rout in drugmaker shares on worries of a government and insurer clampdown on U.S. drug prices. All 18 Democratic members of the House of Representatives Committee on Oversight and Government Reform urged their chairman to subpoena Valeant Pharmaceuticals […]

Read More »

UK scientists start stem cell trial of potential blindness cure

The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness. Specialists at London’s Moorfields Eye Hospital said the operation, described as “successful”, was the first of 10 planned for participants […]

Read More »

Page 1 of 1012345...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom